Author:
Ishizawa Sho,Takahashi-Fujigasaki Junko,Kanazawa Yasushi,Matoba Keiichiro,Kawanami Daiji,Yokota Tamotsu,Iwamoto Takeo,Tajima Naoko,Manome Yoshinobu,Utsunomiya Kazunori
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference28 articles.
1. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397–407. doi: 10.1038/nrm1103 .
2. Yatomi Y. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Curr Pharm Des. 2006;12(5):575–87.
3. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH. International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev. 2010;62(4):579–87. doi: 10.1124/pr.110.003111 .
4. Randriamboavonjy V, Badenhoop K, Schmidt H, Geisslinger G, Fisslthaler B, Fleming I. The S1P(2) receptor expressed in human platelets is linked to the RhoA–Rho kinase pathway and is down regulated in type 2 diabetes. Basic Res Cardiol. 2009;104(3):333–40. doi: 10.1007/s00395-008-0769-1 .
5. Fox TE, Bewley MC, Unrath KA, Pedersen MM, Anderson RE, Jung DY, et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res. 2011;52(3):509–17. doi: 10.1194/jlr.M010595 .
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献